Structural Formula (Divalproexertablet Figure 01)
Divalproex Sodium Tablet, Film Coated, Extended Release
Product Images NDC 68001-105
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 68001-105). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Divalproexertablet Figure 02)
Figure 2 (Divalproexertablet Figure 03)
This document appears to be a chart or graph showing the percentage reduction in CPS rate for two different doses of delayed-release divalproex sodium tablets. The chart shows that at a high dose, there is a 50% improvement rate, while at a low dose, there is no change or worsening. There is no further context or explanation provided.*
Figure 3 (Divalproexertablet Figure 04)
Divalproex Sodium Er Tablets 250mg 100tablets Rev 04-17 (Image 01)
Once-Daily Dosing extended-release tablets of Divalproex Sodium in 250mg strength are available in a pack of 10 tablets with the NDC code 68001-105-00 Rx Only. The tablets are used to treat various medical conditions but their specific use is not mentioned. Storage instructions advise to keep them at the temperature of 27°C to 25°C and in dry conditions. The validity of the medication should be checked before use. The text also contains some unclear characters that could not be evaluated in any particular language.*
Divalproex Sodium Er Tablets 500mg 100tablets Rev 04-17 (Image 02)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
